DWTX: Phase 2 Long COVID Results Expected Soon
On November 7, 2024, Dogwood Therapeutics, Inc. (DWTX) announced financial results for the third quarter of 2024 and provided a business...
Dogwood Therapeutics, Inc. - DWTX: Virios Therapeutics Becomes Dogwood Therapeutics
On October 7, 2024, Virios Therapeutics, Inc. (VIRI) announced a business combination with privately-held Wex Pharmaceuticals, Inc. to form Dogwood...
VIRI: Enrollment Complete in Phase 2a Long COVID Trial Results Expected in October 2024
On August 8, 2024, Virios Therapeutics, Inc. (VIRI) announced financial results for the second quarter of 2024 and provided a business update. The...
VIRI: Results for Phase 2 Long COVID Trial Expected in 2H24
On May 10, 2024, Virios Therapeutics, Inc. (VIRI) announced financial results for the first quarter of 2024 and provided a business update. The...
No more insights